Who has invested in Pathalys Pharma?

DaVita Venture Group, Catalys Pacific are named among the investors backing Pathalys Pharma.

Pathalys Pharma Funding: $105M Raised, Series B (2024)

Pathalys Pharma funding overview

Pathalys Pharma is based in Research Triangle Park, NC. Pathalys Pharma has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2024. The round record for Pathalys Pharma runs through 2024; nothing later has been disclosed. Investors on record include DaVita Venture Group, Catalys Pacific. 2 distinct backers are named across the disclosed rounds.

Pathalys Pharma at a glance

Total raised: $105M
Latest round: Series B
Latest round date: August 2024
Headquarters: Research Triangle Park, NC
Notable investors: DaVita Venture Group, Catalys Pacific

Frequently asked about Pathalys Pharma funding

How much has Pathalys Pharma raised?: Pathalys Pharma has raised $105M in total disclosed funding across the rounds on record.
Who has invested in Pathalys Pharma?: DaVita Venture Group, Catalys Pacific are named among the investors backing Pathalys Pharma.
What was the latest Pathalys Pharma funding round?: The most recent disclosed round is a Series B, announced in August 2024.
Where is Pathalys Pharma based?: Pathalys Pharma is based in Research Triangle Park, NC.
When did Pathalys Pharma last raise?: The last disclosed Pathalys Pharma round closed in August 2024 at Series B.

Round data for Pathalys Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Research Triangle Park and backer lists below.

Pathalys Pharma Funding: $105M Raised, Series B (2024)

Pathalys Pharma funding overview

Pathalys Pharma at a glance

Frequently asked about Pathalys Pharma funding

Companies related to Pathalys Pharma (39)

Browse related funding lists (3)